Egis Jumps to Week High on EU Drug Sale Approval: Budapest Mover

Egis Nyrt., the Hungarian drugmaker owned by Laboratoires Servier, jumped to the highest in more than a week after getting European Commission approval for the sale of its Remsima drug.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.